City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation's top cancer centers by U.S ...

This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in ...

Recent GLP-1 (glucagon-like peptide-1) obesity treatments such as ‘Wegovy’ and ‘Mounjaro’ have gained immense popularity, but ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most common side effect of semaglutide, the ...

Tia Timmer was always “on the heavier side,” but her weight never held her back – until she had to keep up with two grandchildren.

Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...

Jackée Harry spoke to PEOPLE about taking a GLP-1 medication for pre-diabetes. The actress lost 50 lbs. and ultimately ...

About half (53%) of Americans say they hear or read about Ozempic, Wegovy and similar drugs extremely or very often.

At a high level these drugs mimic glucagon-like peptide-1, or GLP-1, a hormone our bodies naturally produce in the gut. When ...

ALV-100 is a bifunctional glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist / glucagon-like peptide-1 receptor (GLP-1R) agonist fusion protein designed to address long-term ...

Type 2 diabetes medication Glucagon-like Peptide-1, also known as GLP-1, has grown into a popular weight loss treatment in ...

GLP-1 RA use is associated with improved survival and lower hospitalization rates in patients with type 2 diabetes receiving cancer therapy.